TFSA Wealth Plan: The Single Canadian Stock for Million-Dollar Success

Here’s why Kits Eyecare is a top TSX stock that should be on the radar of TFSA investors in October 2025.

| More on:
a person watches stock market trades

Source: Getty Images

Key Points

  • Kits Eyecare (TSX:KITS) leverages a digital eyecare platform with significant growth potential, having doubled its shareholder returns since its initial public offering in 2021 and delivering robust Q2 results, highlighted by a 31% revenue increase and consistent positive EBITDA.
  • The company demonstrates strong performance in its eyeglasses segment, with substantial gains in customer acquisition and premium product sales, driven by strategic marketing and enhancements to the customer experience through innovations like OpticianAI.
  • Analysts forecast significant growth in sales and earnings, with the potential for the stock to double over the next 18 months, positioning Kits Eyecare as an attractive investment choice for TFSA holders seeking substantial long-term returns.

The Tax-Free Savings Account (TFSA) is a popular registered account in Canada due to its tax-sheltered status. Any returns generated in a TFSA from qualified investments are exempt from Canada Revenue Agency taxes, making it an ideal choice for investors with a sizable risk appetite.

For instance, Canadian investors should consider owning quality growth stocks in the TFSA to derive market-beating returns over time. In this article, I have identified one such Canadian stock that should be part of your TFSA right now.

The bull case for this TSX stock

Valued at $575 million by market cap, Kits Eyecare (TSX:KITS) operates a digital eyecare platform in the United States and Canada. It is a vertically integrated digital eyewear brand that offers an extensive range of eyeglasses, sunglasses, contact lenses, and vision care products.

KITS aims to revolutionize the eyewear industry by providing a seamless online shopping experience, fast delivery, and exceptional customer care. The TSX stock went public in early 2021 and has since doubled shareholder returns.

Kits Eyecare delivered record revenue of $49.6 million in Q2, representing a 31% year-over-year increase. It reported an adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $2.6 million, indicating a margin of 5.2%.  It was the company’s 11th consecutive quarter of positive adjusted EBITDA. The standout performer was the eyeglasses business, which grew 44% year-over-year to $7.2 million in sales.

Kits delivered over 112,000 pairs of glasses during the quarter, representing a 53% increase from the prior year. Premium lens upgrades accounted for nearly 46% of glasses revenue and grew by 58% year-over-year, indicating that customers are increasingly choosing higher-value products. Returning customers now represent over 52,000 glasses deliveries, up 18% year-over-year.

Growth driven by AI and repeat business

Revenue originating from Canada increased by 44%, driven by new and returning customers across various product categories. Management noted this growth came despite Kits still having minimal market presence and brand awareness in most Canadian regions, suggesting a significant runway ahead.

The company added a record 111,000 new customers during the quarter, up 55% year-over-year, bringing the two-year active customer base to over 991,000 people. New customers contributed over 39% of revenue. To support this growth, marketing spend increased to 15.2% of revenue from 13.4% the previous year, reflecting strategic investments in customer acquisition programs, such as “first pair free” promotions.

Gross margins expanded 350 basis points year-over-year to 36.3%, benefiting from a higher glasses mix and improved operational efficiency. Management reiterated its long-term target of reaching 45% gross margins within three to five years, with adjusted EBITDA margins eventually reaching 15% to 20%.

Kits also launched OpticianAI during the quarter, a tool that helps customers select frames based on their unique measurements, prescription, and style preferences. Early feedback suggests customers view the online experience as superior to traditional retail for frame fitting.

For the third quarter, Kits expects revenue to be between $52 million and $54 million, with adjusted EBITDA margins of 5% to 7%, implying continued momentum in both growth and profitability.

Is the TSX stock undervalued?

Analysts tracking KITS stock forecast sales to rise from $159.3 million in 2024 to $356.6 million in 2027. Comparatively, adjusted earnings per share are estimated to expand from $0.04 to $0.48 in this period.

Moreover, free cash flow is projected to improve from $10 million in 2024 to $30 million in 2027. If the TSX stock is priced at 35 times forward FCF, it should double over the next 18 months.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kits Eyecare. The Motley Fool has a disclosure policy.

More on Tech Stocks

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold In 2026

Down over 50% from all-time highs, Well Health stock offers significant upside potential to shareholders in December 2025.

Read more »

container trucks and cargo planes are part of global logistics system
Stocks for Beginners

TFSA: 3 Premier Canadian Stocks for Your $10,000 Contribution

Invest in your future with high quality Canadian stocks for your TFSA. Discover three stocks offering significant growth potential.

Read more »

Female raising hands enjoying vacation, standing on background of blue cloudless sky.
Tech Stocks

If You Were Waiting for Tech Stocks to Go on Sale, Now’s Your Chance

Tech stocks, like Constellation Software (TSX:CSU), might be terrific bargains amid volatility.

Read more »

visualization of a digital brain
Tech Stocks

The AI Stocks I’m Seriously Considering After the Tech Wreck

Shopify (TSX:SHOP) stock is a seriously impressive stock that just had a great Black Friday.

Read more »

Engineers walk through a facility.
Tech Stocks

TFSA Investors: How to Invest $7,000 in 2026?

TFSA investors should consider investing in diversified index funds and undervalued growth stocks to derive inflation-beating returns.

Read more »

gift is bigger than the other
Tech Stocks

1 Oversold TSX Tech Stock to Buy and Hold in December 2025

Down almost 55% from its 52-week high, CMG is a TSX tech stock that offers significant upside potential in December…

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Dividend Stocks

This Under-the-Radar Tech Stock Can Be Canada’s Next Unicorn

This under-the-radar Canadian power-tech supplier rides AI data centres and electrification, and could quietly compound into a unicorn.

Read more »

investor looks at volatility chart
Tech Stocks

This Soaring Canadian AI Stock Still Trades at a 33% Discount in December 2025

Down 14% from all-time highs, Celestica is an AI stock that trades at a discount to consensus price targets in…

Read more »